Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review

nork Calverley, Peter, Rogliani, Paola, Papi, Alberto
Argitaratua izan da Drug Saf (2020)

Rate of Decline of FEV(1) as a Biomarker of Survival?

nork Papi, Alberto, Beghé, Bianca, Fabbri, Leonardo M.
Argitaratua izan da Am J Respir Crit Care Med (2021)

Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and Beyond

nork Saturni, Sara, Contoli, Marco, Spanevello, Antonio, Papi, Alberto
Argitaratua izan da Allergy Asthma Immunol Res (2015)

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not “frequent exacerbators”: a post hoc analysis of the FORWARD study

nork Singh, Dave, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Argitaratua izan da Int J Chron Obstruct Pulmon Dis (2017)

Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study

nork Papi, Alberto, Di Stefano, Andrea F. D., Radicioni, Milko
Argitaratua izan da Adv Ther (2020)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD

nork Scichilone, Nicola, Benfante, Alida, Morandi, Luca, Bellini, Federico, Papi, Alberto
Argitaratua izan da Patient Relat Outcome Meas (2014)

Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease

nork Singh, Dave, Corradi, Massimo, Spinola, Monica, Petruzzelli, Stefano, Papi, Alberto
Argitaratua izan da NPJ Prim Care Respir Med (2016)

Mechanisms of rhinovirus-induced asthma

nork Papadopoulos, Nikolaos G, Papi, Alberto, Psarras, Stelios, Johnston, Sebastian L
Argitaratua izan da Paediatr Respir Rev (2004)

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations

nork Nicolini, Gabriele, Scichilone, Nicola, Bizzi, Andrea, Papi, Alberto, Fabbri, Leonardo M
Argitaratua 2008

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

nork Vanfleteren, Lowie, Fabbri, Leonardo M, Papi, Alberto, Petruzzelli, Stefano, Celli, Bartolome
Argitaratua izan da Int J Chron Obstruct Pulmon Dis (2018)

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

nork Singh, Dave, Fabbri, Leonardo M, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Argitaratua izan da Int J Chron Obstruct Pulmon Dis (2019)

Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease

nork Pascoe, Steven J., Papi, Alberto, Midwinter, Dawn, Lettis, Sally, Barnes, Neil
Argitaratua izan da Respir Res (2019)

Models of infection and exacerbations in COPD

nork Papi, Alberto, Contoli, Marco, Gaetano, Caramori, Mallia, Patrick, Johnston, Sebastian L
Argitaratua izan da Curr Opin Pharmacol (2007)

Management of chronic refractory cough in adults

nork Visca, Dina, Beghè, Bianca, Fabbri, Leonardo Michele, Papi, Alberto, Spanevello, Antonio
Argitaratua izan da Eur J Intern Med (2020)

New drugs targeting Th2 lymphocytes in asthma

nork Caramori, Gaetano, Groneberg, David, Ito, Kazuhiro, Casolari, Paolo, Adcock, Ian M, Papi, Alberto
Argitaratua 2008

A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with...

nork Virchow, J. Christian, Rodriguez-Roisin, Roberto, Papi, Alberto, Shah, Tushar P., Gopalan, Gokul
Argitaratua izan da BMC Pulm Med (2016)

Treatment strategies for asthma: reshaping the concept of asthma management

nork Papi, Alberto, Blasi, Francesco, Canonica, Giorgio Walter, Morandi, Luca, Richeldi, Luca, Rossi, Andrea
Argitaratua izan da Allergy Asthma Clin Immunol (2020)

ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy

nork Cruz, Álvaro A., Barile, Sara, Nudo, Elena, Brogelli, Laura, Guller, Patricia, Papi, Alberto
Argitaratua izan da Asthma Res Pract (2021)

Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial

nork Papi, Alberto, Nicolini, Gabriele, Crimi, Nunzio, Fabbri, Leonardo, Olivieri, Dario, Rossi, Andrea, Paggiaro, Pierluigi
Argitaratua 2012

The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD

nork Papi, Alberto, Jones, Paul W, Dalvi, Prashant S, McAulay, Kirsten, McIver, Tammy, Dissanayake, Sanjeeva
Argitaratua izan da Int J Chron Obstruct Pulmon Dis (2015)